Novonesis A/S (OTC:NVZMY - Get Free Report)'s share price rose 6.4% during trading on Thursday . The stock traded as high as $60.82 and last traded at $59.31. Approximately 96,785 shares traded hands during trading, an increase of 201% from the average daily volume of 32,134 shares. The stock had previously closed at $55.73.
Novonesis A/S Price Performance
The stock has a market capitalization of $28.80 billion, a price-to-earnings ratio of 38.92, a price-to-earnings-growth ratio of 2.79 and a beta of 0.91. The business has a 50 day moving average of $58.55.
Novonesis A/S Company Profile
(
Get Free Report)
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
See Also
Before you consider Novonesis A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novonesis A/S wasn't on the list.
While Novonesis A/S currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
